Statistics for First-line Treatment with Long-acting Risperidone in Subjects with First-Episode Psychosis: Safety and Efficacy Results from a 6-month Interim Analysis.
Total visits
| views | |
|---|---|
| First-line Treatment with Long-acting Risperidone in Subjects with First-Episode Psychosis: Safety and Efficacy Results from a 6-month Interim Analysis. | 0 |
Total visits per month
| views | |
|---|---|
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |